头皮状细胞癌的无疾病生存预后小组:随机临床试验的二次分析
在PubMed上查看摘要
概括
此摘要是机器生成的。皮肤状细胞癌风险高的患者,按节外延伸和节点大小≥22mm定义,在放射治疗后的无病存活率较低. 这些患者可能会在未来的临床试验中受益于强化辅助治疗策略.
科学领域
- 癌症学
- 头癌研究
- 放射治疗的有效性
背景情况
- 皮肤状细胞癌 (cSCC) 是常见的,其中约5%具有高风险特征,如结节转移.
- 术后放射治疗 (PORT) 改善了高风险cSCC的结果.
- 根据TROG 05. 01试验,同时进行的化疗对该组PORT没有任何额外的益处.
研究的目的
- 在PORT后识别患有不良无病生存期 (DFS) 的患者.
- 确定未来辅助治疗试验的高危子组.
主要方法
- 对TROG 05. 01第三阶段随机试验的二次分析 (N=321).
- 递归分区分析 (分类树和回归树) 以确定预后子组.
- 无病存活率 (DFS) 和整体存活率 (OS) 是主要和次要终点.
主要成果
- 鉴定出一个高危子组 (n=88) 的外节延伸和节点大小≥22mm.
- 与非高风险组相比,该高风险组的5年DFS (56%) 和OS (59%) 显著降低.
- DFS和OS的危险比分分别为2.0和3.2,有利于非高危人群.
结论
- 外节延伸和节点大小≥22mm定义了一个高风险的cSCC子组,后PORTDFS较差.
- 这一小组可能受益于强化辅助治疗策略.
- 未来的临床试验应集中在已确定的高风险人群中.
相关概念视频
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

